Scholarlink

Background <p>Detection of axillary lymph node (LN) involvement is essential for staging breast cancer and optimizing treatment. This proof-of-concept two-center study explored the feasibility of magnetic resonance imaging (MRI) radiomics-based machine learning models to predict LN involvement and compare their performance with node reporting and data system (Node-RADS).</p> Materials and methods <p>We retrospectively included breast cancer patients undergoing preoperative multiparametric MRI and LN dissection (January 2020–September 2024). Stable radiomic features (intraclass correlation coefficient ≥ 0.75) were extracted from contrast-enhanced, subtracted, and T2-weighted sequences. Five machine learning models were trained for binary LN involvement classification, using histopathology as a reference standard. The best-performing model was externally validated on an independent cohort. Performance metrics included sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the receiver operating characteristic curve (AUROC). Node-RADS (scores &gt; 2 indicating LN involvement) was used for comparison in the external dataset.</p> Results <p>Of 93 cases, 40 (43%) were LN involvement-positive; 17 stable features were selected for model development. The best-performing model achieved 81% AUROC (95% confidence interval 78–85%), 75% accuracy (70–79%), 52% sensitivity (41–62%), 92% specificity (86–98%), 85% PPV (76–95%), and 72% NPV (68–76%) on the internal dataset. External validation (18 cases) showed promising results: 94% AUROC (89−99%), 89% sensitivity (52–100%), 100% specificity (66–100%); in this small cohort, accuracy, sensitivity, and specificity did not differ significantly <i>versus</i> Node-RADS, with moderate agreement (Cohen κ = 0.47).</p> Conclusion <p>In this preliminary series, the model showed performance metrics in predicting LN involvement comparable to Node-RADS.</p> Relevance statement <p>Radiomics-based MRI models may represent a promising investigational tool for noninvasive axillary LN assessment in breast cancer. The performance comparable to Node-RADS suggests a potential to support clinical decision-making in the context of axillary de-escalation surgery.</p> Key Points <p><UnorderedList Mark="Bullet"> <ItemContent> <p>Radiomics uses MRI to predict breast cancer LN involvement non-invasively and accurately.</p> </ItemContent> <ItemContent> <p>Radiomics and Node-RADS showed comparable performance.</p> </ItemContent> <ItemContent> <p>Radiomics could reduce invasive procedures, supporting personalized treatments in breast cancer care.</p> </ItemContent> </UnorderedList></p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Radiomics-based MRI models for predicting breast cancer axillary lymph node involvement in comparison with Node-RADS: a proof-of-concept study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月2日

查看全文
  • Roberto Maroncelli,
  • Veronica Rizzo,
  • Marcella Pasculli,
  • Sara Coppola,
  • Chiara De Nardo,
  • Marco Moschetta,
  • Carlo Catalano,
  • Federica Pediconi

摘要

Background

Detection of axillary lymph node (LN) involvement is essential for staging breast cancer and optimizing treatment. This proof-of-concept two-center study explored the feasibility of magnetic resonance imaging (MRI) radiomics-based machine learning models to predict LN involvement and compare their performance with node reporting and data system (Node-RADS).

Materials and methods

We retrospectively included breast cancer patients undergoing preoperative multiparametric MRI and LN dissection (January 2020–September 2024). Stable radiomic features (intraclass correlation coefficient ≥ 0.75) were extracted from contrast-enhanced, subtracted, and T2-weighted sequences. Five machine learning models were trained for binary LN involvement classification, using histopathology as a reference standard. The best-performing model was externally validated on an independent cohort. Performance metrics included sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the receiver operating characteristic curve (AUROC). Node-RADS (scores > 2 indicating LN involvement) was used for comparison in the external dataset.

Results

Of 93 cases, 40 (43%) were LN involvement-positive; 17 stable features were selected for model development. The best-performing model achieved 81% AUROC (95% confidence interval 78–85%), 75% accuracy (70–79%), 52% sensitivity (41–62%), 92% specificity (86–98%), 85% PPV (76–95%), and 72% NPV (68–76%) on the internal dataset. External validation (18 cases) showed promising results: 94% AUROC (89−99%), 89% sensitivity (52–100%), 100% specificity (66–100%); in this small cohort, accuracy, sensitivity, and specificity did not differ significantly versus Node-RADS, with moderate agreement (Cohen κ = 0.47).

Conclusion

In this preliminary series, the model showed performance metrics in predicting LN involvement comparable to Node-RADS.

Relevance statement

Radiomics-based MRI models may represent a promising investigational tool for noninvasive axillary LN assessment in breast cancer. The performance comparable to Node-RADS suggests a potential to support clinical decision-making in the context of axillary de-escalation surgery.

Key Points

Radiomics uses MRI to predict breast cancer LN involvement non-invasively and accurately.

Radiomics and Node-RADS showed comparable performance.

Radiomics could reduce invasive procedures, supporting personalized treatments in breast cancer care.

Graphical Abstract